Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

✍ Scribed by Hirokazu Nagai; Michinori Ogura; Shigeru Kusumoto; Naoto Takahashi; Motoko Yamaguchi; Nobuyuki Takayama; Tomohiro Kinoshita; Toshiko Motoji; Kazuma Ohyashiki; Hiroshi Kosugi; Shin Matsuda; Kazunori Ohnishi; Ken Omachi; Tomomitsu Hotta

• Book ID: 114794875
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 145 KB
• Volume: 86
• Category: Article
• ISSN: 0902-4441
• DOI: 10.1111/j.1600-0609.2010.01552.x